Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -30.00 -2.34% 1,252.00 1,246.00 1,256.00 1,284.00 1,252.00 1,284.00 58,860 16:28:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.3 0.7 1.0 1,252.0 495

Biotech Growth Share Discussion Threads

Showing 26 to 50 of 325 messages
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
DateSubjectAuthorDiscuss
19/1/2013
22:20
Just found it - http://www.ibtplc.com/assets/images/IBT%20Presentation%20AGM_05Dec12.pdf
davebowler
19/1/2013
22:18
Yes but its not quantified here-http://www.ibtplc.com/fact_sheets/2012/December2012.pdf
davebowler
19/1/2013
20:49
Doesn't IBT set aside part of its portfolio for unlisted companies?
1066monkey
17/1/2013
13:40
BIOG is at a 1% premium http://www.trustnet.com/Factsheets/Factsheet.aspx?fundCode=AKFR0&univ=T whereas IBT (similar) is at a 16% discount.http://www.trustnet.com/Factsheets/Factsheet.aspx?fundCode=ITIBT&univ=T
davebowler
16/1/2013
23:01
What's your problem Flips? Can't read too well, or tunnel vision? I was simply exchanging opinions with Monk about an AIM listed biotech investment trust. If you have something to say about BIOG why not say it instead of whinging.
yiyack3
16/1/2013
09:13
yiyack Surely this is a thread aobut an investment Trust, Biotech Growth. It is largely invested in Us stocks. Why do you keep talking about AIM?
flips
15/1/2013
22:19
Over on the sharecrazy.com site there's wise old guy, Malcolm Stacey. With AIM shares like this he advises making a small initial investment - say £300. If it goes up, buy more. If it goes down 10% or more, sell with only a small loss. Buy your winners, sell the losers, and with high risk shares keep the risk under control. Sounds good to me and the only way I will get involved with AIM shares.
yiyack3
15/1/2013
11:11
Yeah, the 3 year is a bit of a slow motion car crash. The thing that's attractive is the nav is almost 10p but the market can definitely remain irrational longer than I can remain solvent.
1066monkey
14/1/2013
23:24
Monk, good luck if you do, but look at the chart, I wouldn't touch it with yours.
yiyack3
14/1/2013
16:17
Yiyack3 Haha...You might be right but this one is run by Jim Mellon who wrote Cracking the Code and has some expertise in biotech stock picking. He's worth several hundred million so I suspect that he's not in it for the money. Appreciate where you're coming from though.
1066monkey
14/1/2013
00:50
In my experience many AIM companies are pretty well worthless, run by a CEO and a crony or two who like the good life, first class on expenses, get rich as quick as poss and don't worry when the company runs out of cash, goes bust and all the shareholders lose their investments. If an AIM company gets to be popular on the ADVFN and other bulletin boards, do what you can to hitch a ride on rising share price, then take profits and get out. Don't ever believe the story behind an AIM market share
yiyack3
13/1/2013
11:16
Any of you have any thoughts about PEBI? I'm tempted because of the discount to its NAV but at the same time I'm concerned that might persist or even widen. One of the nice things about BIOG is the deviation from NAV isn't that great.
1066monkey
10/1/2013
08:22
Yep, all in my sipp.
philo124
10/1/2013
08:19
Well done, chaps :-) I know very little about Pharma's but i do know they belong in my pension pot so an IT was the perfect answer for me. Let the managers do the work. GL :-))
sawadee3
09/1/2013
22:34
Sawadee, I bought some of these back in 2000. Remember those mini ISAs?, - you could have £3k worth of shares. I bought near the top of the bubble. At last they have recovered and I'm now over £1k in profit. Investment trusts are mostly great. Make a mistake - like I did, buying at that time - and with patience they'll give you your money back. I've been into investment trusts for about 15 years and they have done very well for me. I've never been able to understand the general lack of interest in them, when you get to understand how discounts and gearing work it's hard to lose money.
yiyack3
09/1/2013
12:03
Sorry, PCGH ! Hold BIOG for my 10 year old son- in at £1. This fund clearly the leader.
philo124
09/1/2013
09:16
Hello, Phil, BCGH another Biotech? not showing up in my HL SIPP. Up again today here :-))
sawadee3
08/1/2013
19:44
Try IBT as well. And BCGH.
philo124
08/1/2013
14:09
These investment trust threads sure are quiet aren't they! My IT's, including this one, have been an absolute joy to hold :-) Will be picking some more juicy one's for 2013!
sawadee3
06/8/2012
17:01
Thank you Northernlass, a helpful link. It is one of only 2 equities in my ISA which has been purchased for capital appreciation, the rest for their dividend policy.
erogenous jones
29/7/2012
20:28
Get stuck in to some bang up to date research from Edison: http://www.edisoninvestmentresearch.co.uk/researchreports/BIOG260712review.pdf
northernlass
29/7/2012
20:25
Outperformed NASDAQ Bio Index BIOTECH GROWTH TRUST BEATS BENCHMARK Biotech Growth Trust outperformed its benchmark in the three months to the end of June. The trust's net asset value per share rose by 11.0% compared with a 7.6% rise in the NASDAQ Biotechnology Index measured in sterling terms. The company said the NAV performance was, in part, due to strong returns from portfolio holdings in Questcor Pharmaceuticals, following reports of strong sales of its multiple sclerosis treatment Acthar and also from Onyx Pharmaceuticals, following a positive vote from a US Food & Drug Administration Panel for the approval of its drug Carfilzomib for the treatment of advanced Myeloma. P.S. Here's some links about SCLP, one of the hottest stocks at the moment: http://www.euroinvestor.com/community/discussionthread.aspx?iid=2467508&threadid=256596&mode=2 http://www.euroinvestor.com/community/discussionthread.aspx?iid=2467508&threadid=253089&mode=2 http://www.euroinvestor.com/community/discussionthread.aspx?iid=2467508&threadid=257550&mode=2
northernlass
29/7/2012
20:24
THE QUARTER'S BEST PERFORMER Looking at individual investment portfolios, the Biotech Growth trust was the quarter's best performer in terms of both net asset value (NAV) and share price. Over the three months, its NAV rose 19.1% while share price was up 11.4% on a total return basis. Source: http://www.fundweb.co.uk/investment-trusts/news/trusts-ahead-of-open-ended-peers-despite-q2-underperformance/1053944.article
northernlass
29/7/2012
20:22
PHILO124 You're not kidding either. Take one look at the rising chart and you can see what all the fuss is about.
northernlass
03/7/2012
23:56
The sale was a poor decision.
philo124
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
ADVFN Advertorial
Your Recent History
LSE
BIOG
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200811 02:09:57